Data protection Impressum

Life sciences

At a recent BioAlps INSIDE event in Fribourg, the Biofactory Competence Center showcased how its bioprocess expertise helps partners across Western Switzerland move from research to production, with collaborations spanning Lausanne start-up Regenosca and the CHUV.

Fribourg’s Biofactory Competence Center turns biotech research into scalable production

23 June 2026

SOPHiA GENETICS, the Lausanne-based leader in AI-driven precision medicine, has closed an oversubscribed public offering with gross proceeds of USD 57.5 million to expand its platform, applications and partnerships.

SOPHiA GENETICS raises USD 57.5 million in oversubscribed public offering

22 June 2026

Impli, the deeptech company developing continuous molecular monitoring for hormonal health and present at Biopôle in Lausanne, has been awarded a GBP 1.4 million grant to bring its hormone-monitoring patch toward clinical validation for in vitro fertilization.

Impli secures GBP 1.4 million grant to advance continuous hormone monitoring for IVF

16 June 2026

Geneva-based femtech start-up TrialHer has converted early demand into paid pilots with two companies in the UK and Europe, and was selected to join the WHO/Europe Public Health Innovation Platform.

Geneva femtech TrialHer secures first paid pilots and WHO selection

15 June 2026

Neuchâtel’ CSEM contributed system integration and bonding expertise to the development of Hamilton's GlucoSense, a sensor that delivers continuous glucose monitoring inside bioreactors used in biologics production.

CSEM helps bring real-time glucose monitoring to bioreactor manufacturing

3 June 2026

On 23 and 24 September 2026, ILMAC will take place at Beaulieu Lausanne, positioning the Greater Geneva region at the centre of Switzerland's chemistry and life sciences industry under the banner "Inspiring the Future of Chemistry and Life Sciences."

ILMAC returns in September 2026 to bring together the chemistry and life sciences sector

1 June 2026

Geneva-based MindMaze Therapeutics announced a CHF 8 million strategic equity financing from Neuro.io Group, funding the expansion of its U.S. commercial operations and opening the door to a potential combination of neurotherapeutics and artificial intelligence.

MindMaze secures CHF 8 million to expand its neurotherapeutics platform

1 June 2026

CSEM and MOMM Diagnostics have developed a point-of-care preeclampsia test up to 100 times more sensitive than conventional lateral flow assays.

CSEM and MOMM Diagnostics develop rapid preeclampsia test

26 May 2026

Geneva's Neurosoft Bioelectronics has raised USD 7.5 million in an oversubscribed seed round to advance its brain interface platform and build a cortical AI model.

Neurosoft Bioelectronics raises USD 7.5 million to advance its brain interface platform

26 May 2026

The Swiss Biotech Report 2026 reveals record sector revenues and a landmark year for private funding, as talent and international collaboration continue to underpin Switzerland's position at the forefront of global life sciences.

Swiss Biotech Report 2026: talent and tenacity drive record performance

5 May 2026

1 2 3 4 5 … 28